J2150 — Injection, mannitol, 25% in 50 ml
J2150 is a HCPCS Level II code for injection, mannitol, 25% in 50 ml. It belongs to the Drugs Administered Other Than Oral Method section. It was terminated on September 30, 2025 and is not valid on new claims.
This code has been terminated
CMS terminated J2150 on September 30, 2025. It stays in the file as history — a claim you are auditing from before that date may legitimately carry it — but it must not appear on a new claim. The adjacent codes below are the usual place to look for its replacement.
Medicare coverage: Special coverage instructions apply
There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.
From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.
The CMS record for J2150
- Long descriptor
- Injection, mannitol, 25% in 50 ml
- Short descriptor
- Mannitol injection
- Added
- January 1, 1986
- Terminated
- September 30, 2025
- BETOS
- O1E
- Pricing indicator
- 51 — Other
The official wording. This is what the code means.
CMS's 28-character form, which is what shows up on a remittance advice.
When CMS introduced the code.
When CMS retired it.
Berenson-Eggers Type of Service — CMS's own analytic grouping.
Drugs.
Codes adjacent to J2150
HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J2150 is not quite right, the correct code is very often within a few positions of it.
- J2002Injection, lidocaine hcl in 5% dextrose, 1 mg
- J2003Injection, lidocaine hydrochloride, 1 mg
- J2004Injection, lidocaine hcl with epinephrine, 1 mg
- J2010Injection, lincomycin hcl, up to 300 mg
- J2020Injection, linezolid, 200 mg
- J2021Injection, linezolid (hospira), not therapeutically equivalent to j2020, 200 mg
- J2060Injection, lorazepam, 2 mg
- J2062Loxapine for inhalation, 1 mg
- J2151Injection, mannitol, 250 mg
- J2170Injection, mecasermin, 1 mg
- J2175Injection, meperidine hydrochloride, per 100 mg
- J2180Injection, meperidine and promethazine hcl, up to 50 mg
- J2182Injection, mepolizumab, 1 mg
- J2183Injection, meropenem (wg critical care), not therapeutically equivalent to j2185, 100 mg
- J2184Injection, meropenem (b. braun), not therapeutically equivalent to j2185, 100 mg
- J2185Injection, meropenem, 100 mg
Questions about J2150
What is HCPCS code J2150?
J2150 is a HCPCS Level II code for injection, mannitol, 25% in 50 ml. It sits in the Drugs Administered Other Than Oral Method section.
Does Medicare cover J2150?
The CMS HCPCS file marks J2150 as "Special coverage instructions apply". There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.
Is J2150 still valid?
No. J2150 was terminated on September 30, 2025 and should not be used on new claims.